Today: 17 April 2026
GE Aerospace stock price: repair robots, engine shortages and Airbus supply pressure in focus
14 February 2026
2 mins read

GE Aerospace stock price: repair robots, engine shortages and Airbus supply pressure in focus

New York, Feb 14, 2026, 16:32 EST — The closing bell has sounded.

  • GE Aerospace ended Friday’s session at $315.41, gaining 0.8%.
  • Reuters reported the company is ramping up automation and adopting “Lean” practices to boost jet-engine repair output.
  • Traders are eyeing whether CFM will ramp up LEAP engine shipments, with Airbus pushing suppliers—this as a separate spat with Pratt & Whitney plays out.

GE Aerospace closed out Friday at $315.41, up 0.8%. Investors are now watching aviation’s maintenance bottlenecks, with a U.S. market holiday week on deck.

At its Singapore repair hub, GE is now training robots to handle the kind of precise repair jobs previously done by skilled hands, Reuters reported. The move is aimed at cutting through repair backlogs and alleviating the parts shortages that have left some aircraft grounded for months awaiting maintenance. Chief Executive Larry Culp calls the “Flight Deck” initiative a matter of consistent daily progress, not just a mad dash at the end of the quarter. AirAsia’s Tony Fernandes, meanwhile, is pushing engine manufacturers to “treat us as partners.” Reuters

GE’s CFM joint venture partner Safran has boosted its 2026 outlook, banking on robust demand for civil engine services—a crucial profit lever for the industry. Safran projects recurring operating profit between 6.1 billion and 6.2 billion euros in 2026. The company also reported a 30% jump in civil engine services revenue last year, measured in U.S. dollars.

Right now, the real variable is supply, not demand. Safran CEO Olivier Andries said CFM aims to cover any extra Airbus demand this year, but cautioned, “As with each year, if we can do more we will, but our commitment corresponds with our share of the market.” Airbus has been ratcheting up pressure on its suppliers as it seeks to ramp up A320neo-family production. The company is also still negotiating with rival engine maker Pratt & Whitney over supplies for 2026 and 2027, Reuters reports. Reuters

Outside the immediate supply crunch, attention has turned to CFM’s next move on fuel-efficient engines. According to Reuters, the GE-Safran partnership is weighing a traditional “advanced ducted” engine as a backup, even as it pushes ahead with its open-fan RISE project—promising roughly 20% cuts to fuel use and emissions. “My biggest cost is fuel,” Ryanair boss Michael O’Leary said. GE, for its part, cited CEO Culp’s previous statement: the company remains “all-in on Open Fan.” Reuters

The real action is in the aftermarket: that years-long stretch of parts, repairs, and maintenance trailing every engine sale. Here, grounded planes and parts shortages can flip the script on prices and leverage. “Lean” refers to a collection of shop-floor tactics designed to slice out wasted effort and keep jobs moving.

But there are clear risks here. FlightGlobal noted that Andries admitted there are “lots of challenges” ahead for open-fan engines. Customers, for their part, have raised concerns over durability issues with the newer LEAP engines, as well as the slow rollout of fixes. Some LEAP-1B enhancements aren’t expected to be certified until the first half of 2026. Flight Global

The NYSE is closed Monday for Washington’s Birthday, so GE won’t know until Tuesday if Friday’s bid sticks. Investors are eyeing Airbus’s Feb. 19 report for news on production goals and engine supply — particularly if the Airbus-Pratt discussions shift expectations for CFM shipments.

Stock Market Today

  • Kailera Therapeutics Raises $625M in Largest Biotech IPO Since 2018 to Advance Obesity Pipeline
    April 17, 2026, 5:53 AM EDT. Kailera Therapeutics has raised $625 million in its initial public offering (IPO), marking the largest biotech IPO since Moderna's 2018 debut. The Waltham, Massachusetts-based company sold 39 million shares priced at $16 each on the Nasdaq under the ticker KLRA. Funds will chiefly support development of obesity therapies, including injectable and oral GLP-1 drugs licensed from Jiangsu Hengrui Pharmaceuticals. Kailera plans to invest $625 million in late-stage trials for ribupatide, which showed nearly 18% weight loss in China. Additional money will back phase 3 studies of a daily oral version and other pipeline assets. The company may raise another $93 million if underwriters fully exercise their option. Led by CEO Ron Renaud, Kailera aims to compete in the expanding obesity treatment market with a deep late-stage portfolio.

Latest article

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

17 April 2026
Gold hovered near $4,784 an ounce Friday, set for a fourth weekly gain despite easing 0.1% by 0815 GMT. A 10-day Lebanon-Israel ceasefire and possible U.S.-Iran talks kept investors watching for diplomatic progress. Indian gold imports stalled as banks await new government authorization, leaving over 5 tons stuck at customs. Spot silver rose 0.7% to $78.97, platinum held steady, and palladium slipped 0.1%.
UK Stock Market Today: FTSE 100 Slips as Oil Cushions London Shares, Workspace Tumbles

UK Stock Market Today: FTSE 100 Slips as Oil Cushions London Shares, Workspace Tumbles

17 April 2026
London’s FTSE 100 fell 0.18% to 10,570.49 on Friday, trailing gains in Paris and Frankfurt as investors grew cautious ahead of Iran conflict talks. Workspace shares plunged 14% after warning of lower 2027 profits. Tesco, easyJet, and Dunelm flagged pressure from the conflict and consumer pullback. Brent crude hovered near $98, supporting oil stocks but keeping broader sentiment fragile.
US Stock Market Before Open Today: S&P 500 Futures Hold Near Records as Oil Falls and Netflix Slumps

US Stock Market Before Open Today: S&P 500 Futures Hold Near Records as Oil Falls and Netflix Slumps

17 April 2026
U.S. stock futures were steady early Friday, with the S&P 500 near record highs as oil fell below $100 on hopes for renewed U.S.-Iran talks. Netflix shares dropped after weak guidance and news that chairman Reed Hastings will not seek re-election. The Nasdaq closed at a record for a 12th straight session Thursday. Treasury yields held near 4.32% as markets bet the Federal Reserve will stay on hold this year.
Morgan Stanley stock rebounds after Thursday slide as CPI cools; Fed minutes, Basel rules loom
Previous Story

Morgan Stanley stock rebounds after Thursday slide as CPI cools; Fed minutes, Basel rules loom

Disney stock price rebounds to $105 ahead of holiday week as $4 billion bond sale details emerge
Next Story

Disney stock price rebounds to $105 ahead of holiday week as $4 billion bond sale details emerge

Go toTop